Get Your Personalized Supplement StackSupplement Stack Quiz

Miri

Also known as: Adiponectin, APN, Adiponectin (indirectly related to MIRI research)

Overview

The term "Miri" as a standalone supplement ingredient is not recognized in scientific literature. Instead, "MIRI" refers to Myocardial Ischemia-Reperfusion Injury, a pathological condition where heart tissue is damaged upon restoration of blood flow after a period of oxygen deprivation. Research in this area focuses on identifying and studying protective agents that can mitigate this injury. Adiponectin (APN) is an endogenous protein that has shown significant promise in preclinical studies for its protective effects against MIRI. It is a hormone produced primarily by adipose tissue, playing a crucial role in regulating glucose and fatty acid metabolism. While not a supplement itself, its therapeutic modulation or compounds that enhance its activity are areas of active research for mitigating MIRI.

Benefits

Adiponectin has demonstrated significant protective effects against Myocardial Ischemia-Reperfusion Injury (MIRI) in preclinical animal studies. A systematic review and meta-analysis of animal studies indicated that adiponectin reduces inflammation, apoptosis (programmed cell death), and oxidative stress, thereby limiting myocardial damage. This protective effect is considered strong in animal models, suggesting its potential as a therapeutic target for cardiovascular conditions. However, there is no direct high-quality randomized controlled trial (RCT) evidence for a supplement named "Miri" or for adiponectin as a direct supplement in humans to improve MIRI outcomes. Research on dietary supplements combined with physical conditioning exists for general muscle and cardiovascular health, but specific clinical evidence for MIRI mitigation by supplements is less defined.

How it works

Adiponectin (APN) exerts its protective effects against Myocardial Ischemia-Reperfusion Injury (MIRI) by activating multiple intracellular signaling pathways. These pathways lead to anti-inflammatory, antiapoptotic, and antioxidant effects within myocardial cells. Specifically, APN helps to reduce the production of reactive oxygen species, inhibit inflammatory cytokine release, and prevent cell death during the reperfusion phase following ischemia. By modulating these critical cellular processes, APN helps to preserve myocardial function and reduce the extent of tissue damage.

Side effects

Since "Miri" is not identified as a supplement ingredient, there are no known side effects associated with it. Adiponectin, as an endogenous protein, is naturally present in the body. However, therapeutic modulation or administration of exogenous adiponectin would require rigorous clinical development and safety evaluation. Any potential side effects, drug interactions, or contraindications would be specific to the method of administration, dosage, and the specific formulation used to influence adiponectin levels or activity. Currently, there are no established safety profiles or warnings for adiponectin as a supplement.

Dosage

There are no established dosing guidelines for "Miri" as a supplement, as it is not a recognized supplement ingredient. For adiponectin-related therapies, dosing and administration remain experimental and are not clinically established. Research is ongoing to determine effective and safe ways to modulate adiponectin levels or activity for therapeutic purposes, particularly in the context of Myocardial Ischemia-Reperfusion Injury. Any future clinical applications would require extensive research to determine optimal dosage ranges, timing, and forms of administration, along with safety thresholds.

FAQs

Is 'Miri' a supplement I can buy?

No, 'Miri' is not a recognized supplement ingredient. The term 'MIRI' refers to Myocardial Ischemia-Reperfusion Injury, a medical condition, not a product.

What is Myocardial Ischemia-Reperfusion Injury (MIRI)?

MIRI is heart tissue damage that occurs when blood flow is restored to the heart after a period of oxygen deprivation. It involves oxidative stress, inflammation, and cell death.

Are there any supplements that help with MIRI?

While no supplement named 'Miri' exists, research is exploring compounds like adiponectin, an endogenous protein, for its protective effects against MIRI in preclinical studies. Clinical translation is ongoing.

Is adiponectin available as a supplement?

Adiponectin itself is an endogenous protein. While its therapeutic potential is being studied, it is not currently available as a direct supplement with established clinical dosing or efficacy for MIRI.

Research Sources

https://www.frontiersin.org/journals/nutrition/articles/10.3389/fnut.2025.1636970/full – This network meta-analysis evaluated the effects of dietary supplements combined with physical conditioning on muscle and cardiovascular health. It did not identify a supplement named 'Miri' or directly address the treatment of Myocardial Ischemia-Reperfusion Injury (MIRI) in humans, indicating a lack of clinical evidence for 'Miri' as a supplement.
https://pmc.ncbi.nlm.nih.gov/articles/PMC10874037/ – This systematic review and meta-analysis of preclinical animal studies demonstrated that adiponectin protects against Myocardial Ischemia-Reperfusion Injury (MIRI) by reducing inflammation, apoptosis, and oxidative stress. The study highlighted adiponectin's potential as a therapeutic agent for MIRI, despite limitations such as the lack of clinical trials and dose-response data.
https://pubmed.ncbi.nlm.nih.gov/30824459/ – This source, likely a meta-analysis by O'Bryan et al., focused on multi-ingredient protein supplements for muscle and strength gains. It did not investigate Myocardial Ischemia-Reperfusion Injury (MIRI) or any supplement named 'Miri', further confirming that 'Miri' is not a recognized supplement in this context.